Using a profiling array kit, activities of 96 known transcription factors were compared in AR-positive bladder cancer UMUC3 cells with versus without a non-aromatizable synthetic androgen methyltrienolone (R1881) treatment. This evidence concerns the gene AR and urinary bladder carcinoma.